Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Obach

Showing results (131-140 of 193) with videos related to

Pageof 20
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2018
Metabolism of a 5HT<sub>6</sub> Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug InteractionAarti Sawant-Basak, R Scott Obach, Angela Doran, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 20, 2026
Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvirAmit S Kalgutkar, Heather Eng, Alyssa L Dantonio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 10, 2023
The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous AdministrationNarayan Cheruvu, Esther van Duijn, Pieter A Spigt, et al.
Clinical Pharmacology in Drug Development|September 27, 2018
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous InfusionBrett E Houk, Christine W Alvey, Ravi Visswanathan, et al.
Current Drug Metabolism|December 20, 2003
Reaction phenotyping in drug discovery: moving forward with confidence?J Andrew Williams, Susan I Hurst, Jonathan Bauman, et al.
Journal of Medicinal Chemistry|March 31, 2006
A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in humanFranco Lombardo, R Scott Obach, Frank M Dicapua, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2013
In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay methodLi Di, Karen Atkinson, Christine C Orozco, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2014
Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide)Elaine Tseng, Robert L Walsky, Ricardo A Luzietti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting ApproachAngela C Doran, Woodrow Burchett, Connor Landers, et al.
Journal of Medicinal Chemistry|January 15, 2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass eliminationManthena V S Varma, R Scott Obach, Charles Rotter, et al.
Pageof 20

Showing results (131-140 of 193) with videos related to

Sort By:
Pageof 20
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2018
Metabolism of a 5HT<sub>6</sub> Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug InteractionAarti Sawant-Basak, R Scott Obach, Angela Doran, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 20, 2026
Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvirAmit S Kalgutkar, Heather Eng, Alyssa L Dantonio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 10, 2023
The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous AdministrationNarayan Cheruvu, Esther van Duijn, Pieter A Spigt, et al.
Clinical Pharmacology in Drug Development|September 27, 2018
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous InfusionBrett E Houk, Christine W Alvey, Ravi Visswanathan, et al.
Current Drug Metabolism|December 20, 2003
Reaction phenotyping in drug discovery: moving forward with confidence?J Andrew Williams, Susan I Hurst, Jonathan Bauman, et al.
Journal of Medicinal Chemistry|March 31, 2006
A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in humanFranco Lombardo, R Scott Obach, Frank M Dicapua, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2013
In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay methodLi Di, Karen Atkinson, Christine C Orozco, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2014
Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide)Elaine Tseng, Robert L Walsky, Ricardo A Luzietti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting ApproachAngela C Doran, Woodrow Burchett, Connor Landers, et al.
Journal of Medicinal Chemistry|January 15, 2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass eliminationManthena V S Varma, R Scott Obach, Charles Rotter, et al.
Pageof 20